Beyond the Nutritional Use of Klamath Microalgae (Aphanizomenon flos-aquae): Safety, Regulatory Challenges and Emerging Health Benefits

Aphanizomenon flos-aquae (AFA), commonly known as Klamath algae, is a freshwater cyanobacterium harvested mainly from Upper Klamath Lake (Oregon, USA) and widely marketed as a nutraceutical ingredient. Its biomass is characterized by a rich nutritional profile, including proteins, vitamins, minerals, phycocyanins, phenylethylamine (PEA), mycosporine-like amino acids (MAAs), and other bioactive compounds with antioxidant, anti-inflammatory, and neuromodulatory properties. Preclinical evidence indicates that AFA extracts may exert neuroprotective effects through the modulation of oxidative stress, neuroinflammation, amyloid aggregation, and monoaminergic neurotransmission. Beneficial activities have also been reported in experimental models of inflammatory bowel disease and obesity-related metabolic dysfunction, where AFA reduces inflammation, improves metabolic parameters, and modulates epigenetic pathways. Clinical evidence remains limited but suggests potential benefits as a source of bioavailable vitamin B12 and in improving mood and cognition-related symptoms. Despite its long history of use, safety remains closely linked to product quality, because commercial AFA is predominantly harvested from natural blooms, where contamination by cyanotoxins, heavy metals, and other microorganisms may occur. Overall, AFA represents a promising and sustainable nutraceutical resource, although larger clinical studies and rigorous quality-control strategies are required to fully validate its efficacy and safety.

Authors

Institutions

Publication Details

Journal
Antioxidants
Published
2026-11-19
DOI
https://doi.org/10.3390/antiox15111508
Primary Topic
Seaweed-derived Bioactive Compounds
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Beyond the Nutritional Use of Klamath Microalgae (Aphanizomenon flos-aquae): Safety, Regulatory Challenges and Emerging Health Benefits

Veronica Cocetta, Marco Biagi, Paola Nieri, Monica Montopoli et al.
Antioxidants
Seaweed-derived Bioactive Compounds
article

Beyond the Nutritional Use of Klamath Microalgae (Aphanizomenon flos-aquae): Safety, Regulatory Challenges and Emerging Health Benefits

Veronica Cocetta, Marco Biagi, Paola Nieri, Monica Montopoli, Lara Testai
article en

Abstract

Aphanizomenon flos-aquae (AFA), commonly known as Klamath algae, is a freshwater cyanobacterium harvested mainly from Upper Klamath Lake (Oregon, USA) and widely marketed as a nutraceutical ingredient. Its biomass is characterized by a rich nutritional profile, including proteins, vitamins, minerals, phycocyanins, phenylethylamine (PEA), mycosporine-like amino acids (MAAs), and other bioactive compounds with antioxidant, anti-inflammatory, and neuromodulatory properties. Preclinical evidence indicates that AFA extracts may exert neuroprotective effects through the modulation of oxidative stress, neuroinflammation, amyloid aggregation, and monoaminergic neurotransmission. Beneficial activities have also been reported in experimental models of inflammatory bowel disease and obesity-related metabolic dysfunction, where AFA reduces inflammation, improves metabolic parameters, and modulates epigenetic pathways. Clinical evidence remains limited but suggests potential benefits as a source of bioavailable vitamin B12 and in improving mood and cognition-related symptoms. Despite its long history of use, safety remains closely linked to product quality, because commercial AFA is predominantly harvested from natural blooms, where contamination by cyanotoxins, heavy metals, and other microorganisms may occur. Overall, AFA represents a promising and sustainable nutraceutical resource, although larger clinical studies and rigorous quality-control strategies are required to fully validate its efficacy and safety.

AntioxidantsVol. 15(11)
University of Pisa (IT), University of Parma (IT), University of Padua (IT)
Seaweed-derived Bioactive Compounds
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon